Single cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib

Single cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib / Purroy Zuriguel, N., Tong, Y.E., Lemvigh, C.K., Cieri, N., Li, S., Parry, E.M., Zhang, W., Rassenti, L.Z., Kipps, T.J., Slager, S.L., Kay, N.E., Lesnick, C., Shanafelt, T.D., Ghia, P., Scarfò, L., Livak, K.J., Kharchenko, P.V., Neuberg, D., Olsen, L.R., Fan, J., et al.. - In: BLOOD. - ISSN 0006-4971. - (2022). [10.1182/blood.2021013926]